(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Woman charged in unprovoked stabbing of tourist changing baby's diaper in Macy’s Herald Square store - 2Ukraine demands army of 800,000 under peace plan
- 3Find the Standards of Powerful Cooperation: Accomplishing Cooperative energy and Coordinated effort
- 4Blue Origin's next space tourism flight will break new ground for people with disabilities
- 5Step by step instructions to Guarantee the Strength and Life span of Your Pre-assembled Home
- Finding Your Motivation: Moves toward a Satisfying Life
- Manual for Notorious Fragrances: Immortal Aromas
- Tech Patterns 2023: 12 Advancements to Keep an eye Out For
- Putin critic gets six years in penal colony, vows hunger strike
- Arctic is again the hottest it's been in 125 years, with record-low sea ice, NOAA report says
- US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
- The Solution to Innovative Peculiarity: Analyzing the Fate of Mankind
- Trouvez La Carte De Cr\u00e9dit Id\u00e9ale Pour Vos Besoins En Belgique
- Creative Style: 10 Architects Reclassifying the Business
